Correction to: Nature https://doi.org/10.1038/s41586-024-08300-4 Published online 8 January 2025
In the version of the article initially published, two simulation studies that modelled the effect of germline gene editing on human disease were omitted and have now been added as refs. 20 and 21: Oliynyk, R. T. Quantifying the potential for future gene therapy to lower lifetime risk of polygenic late-onset diseases. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20133352 (2019) and Oliynyk, R. T. Future preventive gene therapy of polygenic diseases from a population genetics perspective. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20205013 (2019). The authors regret this omission and have added a sentence to the main text and a paragraph in the revised Supplementary Note 1.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Visscher, P.M., Gyngell, C., Yengo, L. et al. Author Correction: Heritable polygenic editing: the next frontier in genomic medicine?. Nature 640, E5 (2025). https://doi.org/10.1038/s41586-025-08904-4
Published:
Issue date:
DOI: https://doi.org/10.1038/s41586-025-08904-4
